Endocrinology
Growth Disorders
More in Growth Disorders
News and commentary from the endocrinology world
No adverse events resulted in treatment discontinuation
News and commentary from the endocrinology world
Panelists acknowledge difficulty generating stronger data in ultra-rare disease
Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease
News and commentary from the endocrinology world
News and commentary from the endocrinology world
News and commentary from the endocrinology world
News and commentary from the endocrinology world
Association was more apparent when additionally adjusting for BMI
Octreotide subcutaneous depot also improved treatment satisfaction, quality of life
News and commentary from the endocrinology world
The first spinal muscular atrophy prevalence data based on screening came in lower than expected
Traditional trial-and-error method won't be viable in the near future, researcher says
